Learn more about the Cost of Goods aspect of cell and gene therapies: what is this cost comprised of and how can you reduce it?
About the Author
Division Head Quality Assurance at QbD Group
Dominiek leads the Quality Assurance division at QbD Group, helping life science companies build and maintain GxP-compliant quality management systems.
Expert perspectives delivered to your inbox — pick your interests.
No spam, ever. Unsubscribe anytime.
Keep reading
Orphan strategy decisions go beyond incentives. Learn how regulatory definitions, evidence requirements, timing, and exclusivity across the EU, US, and UK shape early biotech development strategy.
Read more
Learn about nitrosamine impurities in medicinal products, their causes, regulatory guidance, and strategies for risk evaluation and mitigation.
Read more
Explore how Environmental Risk Assessment (ERA) helps ensure medicines heal us without harming the planet, balancing healthcare advances with ecological preservation.
Read moreWe use cookies to enhance your experience
We use essential cookies for site functionality and optional analytics cookies to improve our services. Read our Privacy Policy and Cookie Policy.
